Title

The 2019-2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper

Authors

Stanislaw Stawicki, American College of Academic International Academic Medicine
Rebecca Jeanmonod, American College of Academic International Academic Medicine
Andrew Miller, American College of Academic International Academic Medicine
Lorenzo Paladino, American College of Academic International Academic Medicine
David Gaieski, World Academic Council of Emergency Medicine
Anna Yaffee, American College of Academic International Academic Medicine
Annelies De Wulf, American College of Academic International Academic Medicine
Joydeep Grover, World Academic Council of Emergency Medicine
Thomas Papadimos, American College of Academic International Academic Medicine
Christina Bloem, American College of Academic International Academic Medicine
Sagar Galwankar, American College of Academic International Academic Medicine
Vivek Chauhan, World Academic Council of Emergency Medicine
Michael Firstenberg, World Academic Council of Emergency Medicine
Salvatore DI Somma, World Academic Council of Emergency Medicine
Donald Jeanmonod, American College of Academic International Academic Medicine
Sona Garg, American College of Academic International Academic Medicine
Veronica Tucci, American College of Academic International Academic Medicine
Harry Anderson, World Academic Council of Emergency Medicine
Lateef Fatimah, World Academic Council of Emergency Medicine
Tamara Worlton, World Academic Council of Emergency Medicine
Siddharth Dubhashi, World Academic Council of Emergency Medicine
Krystal Glaze, American College of Academic International Academic Medicine
Sagar Sinha, American College of Academic International Academic Medicine
Ijeoma Opara, American College of Academic International Academic Medicine
Vikas Yellapu, World Academic Council of Emergency Medicine
Dhanashree Kelkar, World Academic Council of Emergency Medicine
Ayman El-Menyar, American College of Academic International Academic Medicine
Vimal Krishnan, American College of Academic International Academic Medicine
S. Venkataramanaiah, World Academic Council of Emergency Medicine
Yan Leyfman, World Academic Council of Emergency Medicine
Hassan Saoud Al Thani, World Academic Council of Emergency Medicine
Prabath B. Nanayakkara, World Academic Council of Emergency Medicine
Sudip Nanda, American College of Academic International Academic Medicine

Document Type

Article

Publication Title

Journal of Global Infectious Diseases

Abstract

What started as a cluster of patients with a mysterious respiratory illness in Wuhan, China, in December 2019, was later determined to be coronavirus disease 2019 (COVID-19). The pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel Betacoronavirus, was subsequently isolated as the causative agent. SARS-CoV-2 is transmitted by respiratory droplets and fomites and presents clinically with fever, fatigue, myalgias, conjunctivitis, anosmia, dysgeusia, sore throat, nasal congestion, cough, dyspnea, nausea, vomiting, and/or diarrhea. In most critical cases, symptoms can escalate into acute respiratory distress syndrome accompanied by a runaway inflammatory cytokine response and multiorgan failure. As of this article's publication date, COVID-19 has spread to approximately 200 countries and territories, with over 4.3 million infections and more than 290,000 deaths as it has escalated into a global pandemic. Public health concerns mount as the situation evolves with an increasing number of infection hotspots around the globe. New information about the virus is emerging just as rapidly. This has led to the prompt development of clinical patient risk stratification tools to aid in determining the need for testing, isolation, monitoring, ventilator support, and disposition. COVID-19 spread is rapid, including imported cases in travelers, cases among close contacts of known infected individuals, and community-acquired cases without a readily identifiable source of infection. Critical shortages of personal protective equipment and ventilators are compounding the stress on overburdened healthcare systems. The continued challenges of social distancing, containment, isolation, and surge capacity in already stressed hospitals, clinics, and emergency departments have led to a swell in technologically-assisted care delivery strategies, such as telemedicine and web-based triage. As the race to develop an effective vaccine intensifies, several clinical trials of antivirals and immune modulators are underway, though no reliable COVID-19-specific therapeutics (inclusive of some potentially effective single and multi-drug regimens) have been identified as of yet. With many nations and regions declaring a state of emergency, unprecedented quarantine, social distancing, and border closing efforts are underway. Implementation of social and physical isolation measures has caused sudden and profound economic hardship, with marked decreases in global trade and local small business activity alike, and full ramifications likely yet to be felt. Current state-of-science, mitigation strategies, possible therapies, ethical considerations for healthcare workers and policymakers, as well as lessons learned for this evolving global threat and the eventual return to a 'new normal' are discussed in this article.

First Page

47

Last Page

93

DOI

10.4103/jgid.jgid_86_20

Publication Date

4-1-2020

This document is currently not available here.

Share

COinS